Authors: Sivaraman, P Nussbaumer, G Landsberg, D

Citation: P. Sivaraman et al., Lack of long-term benefits of steroid withdrawal in renal transplant recipients, AM J KIDNEY, 37(6), 2001, pp. 1162-1169

Authors: Zaltzman, J McAlister, V Russell, D Halloran, P Landsberg, D Busque, S Shoker, A Boucher, A Shapiro, J Tchervenkov, J Peets, J

Citation: J. Zaltzman et al., Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1044-1045

Authors: Busque, S Shoker, A Landsberg, D McAlister, V Halloran, P Shapiro, J Peets, J Schulz, M

Citation: S. Busque et al., Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1266-1267

Authors: Keown, P Cole, E Landsberg, D Shapiro, J Halloran, P Muirhead, N Lawen, J Zaltzman, J Murphy, GF Tan, A Balshaw, R Primmett, D Ngai, J Hendricks, L DuBois-Laviolette, A

Citation: P. Keown et al., Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation, TRANSPLANT, 72(6), 2001, pp. 1024-1032

Authors: Cole, E Landsberg, D Russell, D Zaltzman, J Kiberd, B Caravaggio, C Vasquez, AR Halloran, P

Citation: E. Cole et al., A pilot study of steroid-free immunosuppression in the prevention of acuterejection in renal allograft recipients., TRANSPLANT, 72(5), 2001, pp. 845-850

Authors: Kovarik, JM Moore, R Wolf, P Abendroth, D Landsberg, D Soulillou, JP Gerbeau, C Schmidt, AG

Citation: Jm. Kovarik et al., Screening for basiliximab exposure-response relationships in renal allotransplantation, CLIN TRANSP, 13(1), 1999, pp. 32-38